| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
59,743 |
52,333 |
$15.41M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
53,036 |
46,695 |
$13.87M |
| 90832 |
Psychotherapy, 30 minutes with patient |
23,600 |
16,499 |
$7.27M |
| 90837 |
Psychotherapy, 53 minutes with patient |
22,791 |
14,599 |
$6.54M |
| 90834 |
Psychotherapy, 45 minutes with patient |
19,278 |
13,726 |
$5.59M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
13,821 |
5,181 |
$4.08M |
| X5622 |
|
21,046 |
18,480 |
$3.90M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
10,120 |
9,442 |
$3.20M |
| 90791 |
Psychiatric diagnostic evaluation |
9,042 |
8,545 |
$2.19M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,938 |
7,348 |
$1.07M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,532 |
3,430 |
$976K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
2,893 |
2,826 |
$867K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,193 |
5,664 |
$704K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,822 |
5,381 |
$649K |
| 99442 |
|
1,985 |
1,832 |
$608K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
9,732 |
8,523 |
$563K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,438 |
1,385 |
$437K |
| 99215 |
Prolong outpt/office vis |
1,188 |
1,117 |
$348K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,748 |
3,470 |
$327K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,165 |
1,123 |
$318K |
| 99441 |
|
897 |
836 |
$284K |
| 99443 |
|
753 |
708 |
$239K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
547 |
526 |
$173K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
769 |
711 |
$164K |
| S0281 |
Medical home program, comprehensive care coordination and planning, maintenance of plan |
6,140 |
5,985 |
$157K |
| 99381 |
|
618 |
593 |
$146K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
16,625 |
14,989 |
$130K |
| 93000 |
|
367 |
353 |
$68K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
251 |
193 |
$60K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
1,646 |
1,106 |
$36K |
| G0470 |
Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit |
1,028 |
662 |
$35K |
| 92015 |
Determination of refractive state |
7,894 |
7,706 |
$32K |
| 99188 |
|
8,242 |
7,577 |
$23K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
54 |
41 |
$19K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
16,622 |
15,940 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,308 |
9,689 |
$11K |
| S9446 |
Patient education, not otherwise classified, non-physician provider, group, per session |
492 |
465 |
$8K |
| 80061 |
Lipid panel |
9,657 |
9,192 |
$8K |
| 91320 |
|
324 |
310 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
661 |
645 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,263 |
1,226 |
$3K |
| 90662 |
|
175 |
165 |
$3K |
| 99383 |
|
66 |
63 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
39,119 |
35,353 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,602 |
4,401 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,591 |
4,368 |
$2K |
| 90480 |
|
577 |
571 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
24,786 |
21,876 |
$2K |
| 90686 |
|
14,907 |
13,667 |
$1K |
| 99384 |
|
14 |
12 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
732 |
711 |
$1K |
| 80053 |
Comprehensive metabolic panel |
1,896 |
1,806 |
$857.07 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
9,962 |
9,436 |
$745.30 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,139 |
831 |
$699.48 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
4,744 |
4,501 |
$638.02 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
9,951 |
9,424 |
$627.89 |
| 82043 |
|
1,805 |
1,716 |
$610.62 |
| 82570 |
|
1,807 |
1,720 |
$535.91 |
| 90670 |
|
6,601 |
5,906 |
$464.81 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,966 |
1,362 |
$456.12 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,205 |
1,113 |
$434.36 |
| 20610 |
|
13 |
13 |
$434.00 |
| 97802 |
|
406 |
399 |
$403.37 |
| 87430 |
|
4,907 |
4,651 |
$399.18 |
| 0124A |
|
135 |
124 |
$393.88 |
| 85027 |
|
3,115 |
2,984 |
$391.04 |
| G0008 |
Administration of influenza virus vaccine |
203 |
197 |
$299.50 |
| 90677 |
|
163 |
158 |
$276.99 |
| 82274 |
|
594 |
577 |
$247.52 |
| 90785 |
|
2,502 |
1,719 |
$157.73 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
25,114 |
16,894 |
$150.65 |
| 81025 |
|
6,836 |
6,425 |
$134.51 |
| 76801 |
|
284 |
258 |
$124.16 |
| 97803 |
|
361 |
321 |
$110.53 |
| 90656 |
|
626 |
614 |
$110.24 |
| 90734 |
|
2,107 |
1,843 |
$109.78 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,673 |
2,427 |
$107.16 |
| 85018 |
|
8,875 |
8,158 |
$105.01 |
| 90716 |
|
1,468 |
1,250 |
$104.25 |
| 90715 |
|
3,117 |
2,739 |
$80.86 |
| 87210 |
|
5,303 |
5,020 |
$79.88 |
| 81001 |
|
2,657 |
2,482 |
$79.74 |
| 81003 |
|
4,300 |
4,079 |
$52.05 |
| 83655 |
|
1,351 |
1,207 |
$48.44 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
16,097 |
13,870 |
$36.21 |
| 90707 |
|
1,319 |
1,145 |
$34.00 |
| 80076 |
|
512 |
492 |
$31.13 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
579 |
559 |
$23.87 |
| 92551 |
|
14,403 |
13,241 |
$17.70 |
| 82728 |
|
292 |
282 |
$14.02 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
111 |
107 |
$13.24 |
| 84466 |
|
156 |
151 |
$13.13 |
| 82947 |
|
485 |
448 |
$9.07 |
| 83540 |
|
162 |
157 |
$6.65 |
| 99173 |
|
15,454 |
14,208 |
$6.24 |
| 82950 |
|
810 |
772 |
$0.00 |
| 90698 |
|
4,123 |
3,734 |
$0.00 |
| 90651 |
|
2,946 |
2,621 |
$0.00 |
| 90680 |
|
2,403 |
2,102 |
$0.00 |
| 90696 |
|
1,229 |
1,060 |
$0.00 |
| 90744 |
|
2,122 |
1,897 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
206 |
201 |
$0.00 |
| 96127 |
|
9,042 |
8,371 |
$0.00 |
| 96161 |
|
2,721 |
2,391 |
$0.00 |
| 90474 |
|
2,618 |
2,299 |
$0.00 |
| 90723 |
|
674 |
564 |
$0.00 |
| 87807 |
|
78 |
73 |
$0.00 |
| 90619 |
|
90 |
90 |
$0.00 |
| 94010 |
|
18 |
13 |
$0.00 |
| 91319 |
|
13 |
13 |
$0.00 |
| 0240U |
|
87 |
79 |
$0.00 |
| 92250 |
|
85 |
84 |
$0.00 |
| 92567 |
|
40 |
39 |
$0.00 |
| 91318 |
|
16 |
16 |
$0.00 |
| 90633 |
|
3,795 |
3,366 |
$0.00 |
| 84439 |
|
295 |
284 |
$0.00 |
| H1003 |
Prenatal care, at-risk enhanced service; education |
650 |
628 |
$0.00 |
| 90700 |
|
560 |
472 |
$0.00 |
| 90648 |
|
1,960 |
1,683 |
$0.00 |
| 85610 |
|
383 |
220 |
$0.00 |
| 90710 |
|
1,338 |
1,133 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
931 |
889 |
$0.00 |
| 90691 |
|
32 |
26 |
$0.00 |
| 84460 |
|
114 |
111 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
24 |
24 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
170 |
165 |
$0.00 |
| 90685 |
|
638 |
558 |
$0.00 |
| 90681 |
|
28 |
27 |
$0.00 |
| 90672 |
|
222 |
204 |
$0.00 |
| 84550 |
|
14 |
12 |
$0.00 |
| 90473 |
|
65 |
61 |
$0.00 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
132 |
124 |
$0.00 |
| 84702 |
|
44 |
38 |
$0.00 |
| 90746 |
|
25 |
25 |
$0.00 |